| TIME | Hall A | TIME | Hall B |
| 10:30-17:30 | Pancreatic Cancer Course | ||
| 10:30-12:15 | Session 1 Chairs: Erdal Birol Bostancı, Mustafa Kerem, Cumhur Yeğen, Ümit Akyüz |
||
| 10:30-10:45 |
Pancreatic Surgery Anatomy and Lymphatic Drainage |
||
| 10:45-11:00 |
Which Imaging Method is Ideal in a Patient Suspected of Having Pancreatic Cancer? Resectability and Borderline Concepts with Imaging |
||
| 11:00-11:15 |
When Should Drainage Be Considered in a Patient with Jaundice? Which Drainage is Ideal? ERCP, PTK, or Nasobiliary Stent? There is a resectable mass: Should we perform a biopsy? There is no mass, but there is jaundice, what should we do? |
||
| 11:30-11:45 | When Should a Surgeon Refer a Patient for Neoadjuvant Chemotherapy? Burak Civelek |
||
| 11:45-12:00 |
The role of endo ultrasound in pancreatic cancer |
||
| 13:30-16:30 | Difficult Decisions and Cases in Liver Transplantation Course | 12:00-13:00 | Lunch |
| 13:30-14:45 | Session 1 Chairs: Osman AYDIN, Nuru BAYRAMOV |
13:00-14:45 | Session 2 |
| 13:30-13:45 | Liver Volumemetry and Safe Remaining Liver Volume |
13:00-13:15 |
The Role of PET and OncoSil in Pancreatic Cancer Case Studies |
| 13:45-14:00 | Transplantation in Recipients with Portal Vein Thrombosis |
13:15-13:30 |
First Artery Approach in Pancreatic Head Cancers, Level 1, 2, 3, Dissection Concept, Mesopancreas Concept |
| 14:00-14:15 | Combating Small for Size Syndrome |
13:45-14:00 |
RAMPS, Anterior and Posterior Approach and DPCAR |
| 14:15-14:30 | Transplantation in Cholangiocarcinoma: Where Do We Stand? |
14:00-14:15 |
The Role of Minimally Invasive Surgery in Pancreatic Surgery |
| 14:30-14:45 | Discussion | 14:15-14:45 | Discussion |
| 14:45-15:15 | Coffee Break | 14:45-15:05 | Coffee Break |
| 15:15-16:30 | Session 2 Chairs: Burak IŞIK, Tevfik KÜÇÜKKARTALLAR |
15:05-16:50 | Session 3 |
| 15:15-15:30 | Outflow Problems |
15:05-15:20 |
Ideal Pancreatic Reconstruction Techniques, What Are the Options? |
| 15:30-15:45 | Portal Vein Reconstructions |
15:20-15:35 |
The Role of Interventional Radiology in Complication Management |
| 15:45-16:00 | Multiple Bile Duct Management |
15:35-15:45 | Portal Vein Resection Techniques |
| 16:00-16:10 | Re-transplantation: To Whom, When? |
15:45-15:55 |
Laparoscopic Pancreaticoduodenectomy |
| 16:15-16:30 | Discussion | 15:55-16:15 |
Robotic Pancreaticoduodenectomy: Anatomy and Procedure |
| 16:30-17:20 | Preparing the Hall | 16:15-16:25 |
Arter First Yaklaşım ve Level 1-2-3 Diseksiyon, Triangle Diseksiyon |
| 16:25-16:35 |
Laparoscopic & Robotic Distal Pancreatectomy |
||
| 16:35-16:45 |
Heidelberg Pancreaticojejunostomy |
||
| 16:45-16:55 |
Peng Tekniği |
||
| 16:55-17:55 |
Blumgart Pancreaticojejunostomy |
||
| 17:05-17:15 |
Pancreaticogastrostomy Technique |
||
| 17:15-17:30 | Discussion | ||
| 18:00-19:30 | Opening Remarks Prof. Dr. Sezai Yılmaz, Congress President, Director of İnönü University Liver Transplant Institute and President of the Liver Transplant Association |
|
|
| 19:30 | Akşam Yemeği |
| TIME | Hall A |
| 08:30-11:40 | iLDLT COLLOQUIUM 2026 - Malatya- TÜRKİYE Session 1 Minimal invasive donor hepatectomy Chairs: Yaman Tokat (Türkiye), Aydin Alper (Türkiye) |
| 08:30-09:00 | Laparoscopic donor hepatectomy |
| 09:30-10:00 | Robotic donor hepatectomy |
| 10:00-10:20 | Q & A |
| 10:20-10:30 | Coffee Break |
| 10:30-11:30 | Session 2 Minimal invasive LDLT |
| 10:30-11:00 | Robotic LDLT – part 1 |
| 11:00-11:30 | Robotic LDLT – part 2 |
| 11:30-11:40 | Q & A |
| 11:40-12:00 | Coffee Break |
| 12:00-12:20 | Satellite Symposium- Astellas Pharma |
| 12:20-12:30 | Q & A |
| 12:30-13:30 | Lunch |
| 13:30-14:25 | Session 3 Liver Paired Exchange |
| 13:30-13:45 | ABO-incompatible living donor liver transplantation |
| 13:45-14:00 | Liver Paired Exchange- India experience |
| 14:00-14:15 | Liver Paired Exchange- Türkiye experience |
| 14:15-14:25 | Q & A |
| 14:25-14:35 | Coffee Break |
| 14:35-15:15 | Session 4 Liver Transplantation in Infants Under One Year of Age or Weighing Less Than 10kg |
| 14:35-14:55 | Graft Reduction and Size-Matching Strategies for Infant Recipients |
| 14:55-15:05 | Hepatic Arterial Reconstruction in Infant Liver Transplantation: Advantages of the Artery-First Approach |
| 15:05-15:15 | Q & A |
| 15:15-15:30 | Coffee Break |
| 15:30-16:40 | Session 5 Liver transplantation in hepatocellular carcinoma |
| 15:30-15:45 | Novel Biomarkers in Hepatocellular Carcinoma |
| 15:45-16:00 | LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging |
| 16:00-16:15 | Expanded Criteria for HCC and Pushing the Limits with LDLT |
| 16:15-16:30 | Optimal Screening After Liver Transplantation for HCC |
| 16:30-16:40 | Q & A |
| 16:40-16:50 | Coffee Break |
| 16:50-17:20 | Satellite Symposium- Nobel Chairs: Adil Başkıran Management of hepatitis B patients after liver transplantation Murat Harputluoğlu (Türkiye) |
| TIME | Hall A | TIME | Hall B |
| 08:30-10:05 | Session 1: The World of the Future |
08:00-09:10 |
Oral Presentations1 |
| 08:30-08:45 | Where is Robotic Surgery Heading in Gastrointestinal System Cancers? Robotic Surgery Platforms in the World |
||
| 08:45-09:00 | What are the Innovations that Increase Anastomosis Safety in Minimally Invasive Surgery? |
||
| 09:00-09:15 | What Will Artificial Intelligence Bring to Digestive System Surgeons? |
09:10-10:20 | Oral Presentations2 |
| 09:15-09:30 | What Does Technology Contribute to Surgical Training? How Will Surgical Training Be in the Future? |
||
| 09:30-09:45 | How Will Liver Transplantation Be in the Future? 3D Biological Printers, Genetically Modified Organ Supply, etc. |
||
| 09:45-10:00 | Discussion | ||
| 10:00-10:30 | Coffee Break | 10:20-11:30 | Oral Presentations3 |
| 11:00-12:30 | Session 2: The Role of Minimally Invasive Surgery in Colon and Rectal Cancers |
||
| 11:00-11:15 | The Concept of D1, D2, D3 Dissection and Complete Mesocolic Excision in Colon Cancer, Does the Application of These Surgeries Increase Survival? |
||
| 11:15-11:30 | Robot or Total Mesocolic Excision in Rectal Cancer? |
||
| 11:30-11:45 | Is Clinical Complete Response Predictable in Rectal Cancer? What are the S trategies to Increase Clinical Complete Response? I Saw a Near Complete Response, What Should I Do? |
11:30-12:40 | Oral Presentations4 |
| 11:45-12:00 | When Should We Consider PIPAC in Peritoneal Metastases? Does it Contribute to Survival? |
||
| 12:00-12:15 | Robotic Pelvic and Lateral Lymph Node Dissection, Video Presentation |
||
| 12:15-12:25 | Laparoscopic D3 Lymph Node Dissection, Video Presentation |
||
| 12:25-12:35 | Transanal Surgery Applications Video Presentation |
||
| 12:35-12:45 | Discussion | ||
| 12:45-13:30 | Lunch | 12:45-13:30 | Lunch |
| 13:30-15:00 | Session 3: The Role of Minimally Invasive Surgery in Upper GI Surgery |
13:30-14:40 | Oral Presentations5 |
| 13:30-13:45 | Where is Minimally Invasive Surgery Heading in Esophageal Cancer? Is Robotic Surgery Becoming the Gold Standard? |
||
| 13:45-14:00 | The Role of Minimally Invasive Surgery in Esophagogastric Junction Tumors? Does Neoadjuvant Treatment Compel Surgery? |
||
| 14:00-14:15 | Akalazya için Robotik Heller Miyotomi |
||
| 14:15-14:30 | Minimally Invasive Approach Options and Results in Anastomotic Leaks |
||
| 14:30-14:40 | Robotic Heller Myotomy for Achalasia |
14:40-15:50 | Oral Presentations6 |
| 14:40-14:50 | Laparoscopic / Subtotal and Total Gastrectomy Video Presentation |
||
| 14:50-15:00 | Robotic Subtotal and Total Gastrectomy Video Presentation |
||
| 15:00-15:15 | Discussion | ||
| 15:15-15:30 | Coffee Break | ||
| 15:30-16:00 | Satellite Symposium- Cordamed Chair: Birol Bostancı Current Approaches in Liver Surgery: The Role of da Vinci Robotic Surgery |
15:50-17:00 | Oral Presentations7 |
| 16:00-17:30 | Session 4: The Place of Minimally Invasive Surgery in Liver Surgery |
||
| 16:00-16:15 | The Current State of Minimally Invasive Surgery in Liver Surgery and Where Are We Going? |
||
| 16:15-16:30 | How Can We Increase Remnant Liver Volume as Interventional Radiology? |
||
| 16:30-16:45 | Drainage in Klatskin Tumors: Which Patient Should We Use It For and How? At What Bilirubin Level Should We Perform Surgery? |
17:00-18:10 | Oral Presentations 8 |
| 16:45-17:00 | In Which Cases Should We Prefer Chemosaturation and Hepatic Artery Infusion Pump? |
||
| 17:00-17:10 | Laparoscopic Right/Left Hepatectomy Video Presentation |
||
| 17:10-17:20 | Laparoscopic Segment 7/8 Resection Video Presentation |
||
| 17:20-17:30 | No Touch Klatskin Tumor Resection Video Presentation |
18:10-19:20 | Oral Presentations 9 |
| 17:30-17:45 | Discussion | ||
| 21:00 | Social Night | ||
| TIME | Hall A | TIME | Hall B |
| 08:30-10:15 | Session 1: Obesity and Metabolic Surgery Panel |
07:30-08:40 | Oral Presentations10 |
| 08:30-08:45 | Will Medications Replace Obesity Surgery? |
||
| 08:45-09:00 | What is Failure in Obesity Surgery? Is Revision Surgery an Option? In Which Situation Should We Perform Which Revision Surgery? |
||
| 09:00-09:15 | Does Endoscopic Intervention Used in Obesity Have a Promising Future? |
||
| 09:15-09:30 | Approach to Reflux in Obese Patients |
||
| 09:30-09:40 | Video Presentation of Fistula-Dedunostomy as an Option in Post-Gastric Sleeve Fistula |
||
| 09:40-09:50 | Video Presentation of Revision Surgery Examples |
||
| 09:50-10:00 | Video Presentation of Sleeve Plus Surgical Applications |
||
| 10:00-10:15 | Discussion | ||
| 10:15-10:30 | Coffee Break | ||
| 11:00-12:45 | Session 2: Advanced Endoscopic Interventional and Notes Plan |
||
| 11:00-11:15 | ESD Applications in Upper and Lower GIS: Technical Developments |
||
| 11:15-11:30 | Is POEM an Option in Achalasia? What are its Advantages and Disadvantages? Abdullah Şenlikçi |
||
| 11:30-11:45 | When and to Whom Should Notes Be Performed? |
||
| 11:45-12:00 | Endoscopic Interventions in Complications of Necrotizing Pancreatitis |
||
| 12:15-12:25 | How I Perform POEM: Video Presentation |
||
| 12:25-12:35 | How I Perform ESD: Video Presentation |
||
| 12:35-12:45 | STEER Applications: Video Presentation |
||
| 12:45-13:00 | Discussion | ||
| 13:00-13:30 | Closing |